医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Research progress of peroxisome proliferator-activated receptor α in metabolic diseases

摘要Peroxisome proliferator-activated receptor α (PPAR-α) is a transcription factor activated by ligand receptors and is a subfamily of the nuclear receptor superfamily. The PPAR subfamily consists of three subtypes: PPAR-α (NR1C1), PPAR-β/δ (NR1C2) and PPAR-γ (NR1C3). Among them, PPAR-α is the first discovered transcription factor and the main regulator of fatty acid oxidation homeostasis. Some natural and synthetic ligands can activate PPAR-α, and the activation of PPAR-α through its ligands can modify many of the cells in the cell. Biological processes, these processes are closely related to the energy metabolism mechanism of metabolic diseases, so it represents an important molecular target for the development of new drugs for the treatment of metabolic diseases. The following summarizes the latest progress of PPAR-α and energy metabolism in terms of the structure and distribution of PPAR-α, its role in different tissues, and its role in metabolic diseases, etc., providing a theoretical basis for the prevention and treatment of metabolic diseases.

更多
广告
作者 Guang-Jing Duan [1] Feng Xie [1] Bin Wang [1] Lin Chen [1] Pei-Feng Wei [1] Min Li [1] 学术成果认领
作者单位 College of Pharmacy,Shaanxi University of Chinese Medicine,Xi'an 712046,China [1]
栏目名称
发布时间 2022-01-13(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览9
  • 下载0
海南医科大学学报(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷